Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Diagnostic Roles of Immunohistochemical Markers CK20, CD44, AMACR, and p53 in Urothelial Carcinoma In Situ. | Medicina (Kaunas) | 2023 | 37763728 | PubTator, text mining | PubMed |
| Aggressive variant prostate cancer: A case report and literature review. | World J Clin Cases | 2023 | 37731555 | PubTator, text mining | PubMed |
| GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches. | Front Oncol | 2023 | 37719014 | PubTator, text mining | PubMed |
| Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment. | Nutrients | 2023 | 37686769 | PubTator, text mining | PubMed |
| Identification of the Immune Landscapes and Follicular Helper T Cell-Related Genes for the Diagnosis of Age-Related Macular Degeneration. | Diagnostics (Basel) | 2023 | 37685269 | PubTator, text mining | PubMed |
| Aberrant PI3Kδ splice isoform as a potential biomarker and novel therapeutic target for endocrine cancers. | Front Endocrinol (Lausanne) | 2023 | 37670888 | PubTator, text mining | PubMed |
| Collision tumor of spindle cell lipoma arising from perirenal tissue and acquired cystic disease-associated renal cell carcinoma: A rare case report. | IJU Case Rep | 2023 | 37667768 | PubTator, text mining | PubMed |
| Case Report: A MiT family translocation renal cell carcinoma in the renal pelvis, calyces and upper ureter misdiagnosed as upper tract urothelial carcinoma. | Front Oncol | 2023 | 37664061 | PubTator, text mining | PubMed |
| Cancer of unknown primary eventually diagnosed as poorly differentiated prostate cancer: a case report. | J Med Case Rep | 2023 | 37660062 | PubTator, text mining | PubMed |
| Renal cell carcinoma not otherwise specified: A case report in Indonesia. | Urol Case Rep | 2023 | 37649689 | PubTator, text mining | PubMed |
| Mucinous tubular and spindle cell carcinoma of the kidney: a report of seven cases. | BMC Cancer | 2023 | 37649003 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study. | Asian Pac J Cancer Prev | 2023 | 37642075 | PubTator, text mining | PubMed |
| Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists. | Cancers (Basel) | 2023 | 37627129 | PubTator, text mining | PubMed |
| Recent Advances in Renal Tumors with TSC/mTOR Pathway Abnormalities in Patients with Tuberous Sclerosis Complex and in the Sporadic Setting. | Cancers (Basel) | 2023 | 37627070 | PubTator, text mining | PubMed |
| The Bone Microenvironment Soil in Prostate Cancer Metastasis: An miRNA Approach. | Cancers (Basel) | 2023 | 37627055 | PubTator, text mining | PubMed |
| Indolent mucinous tubular and spindle cell carcinoma of the kidney: A case report and review of the literature. | Oncol Lett | 2023 | 37609375 | PubTator, text mining | PubMed |
| Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications. | Biosens Bioelectron | 2023 | 37591158 | PubTator, text mining | PubMed |
| Imaging findings of succinate dehydrogenase-deficient renal cell carcinoma. | Clin Case Rep | 2023 | 37583565 | PubTator, text mining | PubMed |
| Autoantibody Positivity in Two Bahraini Siblings With a Novel Alpha-Methylacyl-CoA Racemase Mutation. | Cureus | 2023 | 37575761 | PubTator, text mining | PubMed |
| Current advances of liquid biopsies in prostate cancer: Molecular biomarkers. | Mol Ther Oncolytics | 2023 | 37575217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=10